Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Otorhinolaryngologic Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03755921
What this trial is testing

Brief and Intensive Therapy for Dysphagia in Patients With Head and Neck Cancer

Who this might be right for
Deglutition DisordersDysphagiaHead and Neck Cancer+1 more
Federal University of Health Science of Porto Alegre 20
Testing effectiveness (Phase 2)Looking for participantsNCT06323460
What this trial is testing

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Oropharyngeal Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT04743310
What this trial is testing

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Who this might be right for
Central Nervous System Tumor
John Yu 50
Testing effectiveness (Phase 2)UnknownNCT03290820
What this trial is testing

Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 184
Testing effectiveness (Phase 2)Study completedNCT01392235
What this trial is testing

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Recurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 58
Testing effectiveness (Phase 2)UnknownNCT05350891
What this trial is testing

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 77
Not applicableLooking for participantsNCT06743490
What this trial is testing

Capturing Key MG-symptoms Using Smartphone Recordings.

Who this might be right for
Myasthenia GravisFatigue
Leiden University Medical Center 225
Testing effectiveness (Phase 2)Study completedNCT04350190
What this trial is testing

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 25
Large-scale testing (Phase 3)UnknownNCT02610010
What this trial is testing

Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 462
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138989
What this trial is testing

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 10
Early research (Phase 1)Study completedNCT02094625
What this trial is testing

NAC to Prevent Cisplatin-induced Hearing Loss

Who this might be right for
Neuroectodermal Tumors, PrimitiveLiver NeoplasmsOsteosarcoma+1 more
Children's Hospital Los Angeles 52
Large-scale testing (Phase 3)Looking for participantsNCT06675214
What this trial is testing

Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.

Who this might be right for
Nasopharyngeal CarcinomaDe-escalation Therapy
Sun Yat-sen University 586
Large-scale testing (Phase 3)Not Yet RecruitingNCT07116811
What this trial is testing

Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

Who this might be right for
Vestibular SchwannomaFacial Nerve Paralysis
Beijing Tiantan Hospital 364
Testing effectiveness (Phase 2)Study completedNCT00305734
What this trial is testing

Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Recurrent Nasopharyngeal CancerStage IV Nasopharyngeal Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT02128906
What this trial is testing

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Who this might be right for
Squamous Cell Carcinoma
Christopher Wilke 120
Testing effectiveness (Phase 2)Looking for participantsNCT06811844
What this trial is testing

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

Who this might be right for
Nasopharyngeal NeoplasmsPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06987123
What this trial is testing

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 62
Very early researchNot Yet RecruitingNCT06752473
What this trial is testing

KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)EBV
Kousai Bio Co., Ltd. 10
Testing effectiveness (Phase 2)Looking for participantsNCT07749586
What this trial is testing

Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Arvinas Inc. 499
Not applicableStudy completedNCT03989297
What this trial is testing

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Kiang Wu Hospital 104
Next Page